Stocktoria
Yunnan Baiyao Group Co.,Ltd 000538.SZ
CN · XSHE · XSHE · stock · Healthcare · website
Yunnan Baiyao Group Co.,Ltd financials (annual)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | CN¥41.2B | CN¥40.0B | CN¥39.1B | CN¥36.5B |
| Gross profit | CN¥12.2B | CN¥11.2B | CN¥10.4B | CN¥9.6B |
| R&D expense | CN¥350.5M | CN¥337.4M | CN¥336.0M | CN¥336.7M |
| SG&A expense | CN¥4.2B | CN¥3.5B | CN¥3.3B | CN¥2.9B |
| Operating income | CN¥5.0B | CN¥4.8B | CN¥3.9B | CN¥4.2B |
| Interest expense | CN¥24.0M | CN¥63.2M | CN¥49.6M | CN¥67.8M |
| Income tax | CN¥853.3M | CN¥917.6M | CN¥695.5M | CN¥536.6M |
| Net income | CN¥5.2B | CN¥4.7B | CN¥4.1B | CN¥3.0B |
| EPS (diluted) | CN¥2.89 | CN¥2.66 | CN¥2.29 | CN¥1.90 |
| Operating cash flow | CN¥4.6B | CN¥4.3B | CN¥3.5B | CN¥3.2B |
| Free cash flow | CN¥4.1B | CN¥3.6B | CN¥2.9B | CN¥2.8B |
| Cash & equivalents | CN¥9.1B | CN¥10.9B | CN¥14.2B | CN¥13.1B |
| Inventory | CN¥6.2B | CN¥6.3B | CN¥6.4B | CN¥8.0B |
| Goodwill | CN¥300.8M | CN¥97.0M | CN¥104.1M | CN¥129.9M |
| Total assets | CN¥54.3B | CN¥52.9B | CN¥53.8B | CN¥53.3B |
| Total debt | CN¥487.6M | CN¥704.6M | CN¥2.0B | CN¥2.2B |
| Total liabilities | CN¥14.1B | CN¥14.0B | CN¥13.9B | CN¥14.8B |
| Shareholders' equity | CN¥40.0B | CN¥38.8B | CN¥39.9B | CN¥38.5B |
Growth · year-over-year · Revenue CAGR 4.1%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +2.9% | +2.4% | +7.2% | — |
| Net income growth | +8.5% | +16.0% | +36.4% | — |
| EPS growth | +8.6% | +16.2% | +20.5% | — |
| Free cash flow growth | +13.8% | +23.7% | +6.0% | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Computed from company filings · CN · as of 2025-12-31. Figures in CNY. Facts plus Stocktoria's own computed scores — not investment advice.